Meridian Bioscience Inc (NASDAQ:VIVO)
| 31.53 Delayed Data As of Sep 30 |  -0.38 / -1.19%Today’s Change | 17.20 Today|||52-Week Range 34.38 | +54.56% Year-to-Date |
Latest VIVO News | Press Releases
No recent news for Meridian Bioscience Inc.
Today’s Trading
| Previous close | 31.91 |
| Today’s open | 32.08 |
| Day’s range | 31.52 - 32.08 |
| Volume | 8,190 |
| Average volume (3 months) | 656,726 |
| Market cap | $1.4B |
Data as of 4:02pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | +53.17% |
| Earnings growth (this year) | -20.48% |
| Earnings growth (next 5 years) | +17.00% |
| Revenue growth (last year) | +25.32% |
| P/E ratio | 32.2 |
| Price/Sales | 2.66 |
| Price/Book | 4.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CLDXCelldex Therapeutics... | -0.21 | -0.74% |
| MYGNMyriad Genetics Inc | -0.41 | -2.10% |
| VCYTVeracyte Inc | -0.03 | -0.18% |
| CDNACareDx Inc | -0.08 | -0.47% |
Data as of 4:02pm ET, 09/30/2022
Financials
| Next reporting date | November 10, 2022 |
| EPS forecast (this quarter) | $0.15 |
| Annual revenue (last year) | $317.9M |
| Annual profit (last year) | $71.4M |
| Net profit margin | 22.46% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cincinnati, Ohio |
Forecasts
